Efficient transfer of oligonucleotides and plasmid DNA into the whole heart through the coronary artery

Gene Therapy

Volumn 5, Issue 11, 1998, Pages 1472-1480

  Sawa, Y ^a   Kaneda, Y ^a   Bai, H Z ^a   Suzuki, K ^a   Fujimoto, J ^b   Morishita, R ^a   Matsuda, H ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Coronary infusion; Gene transfer; HVJ liposome; Myocardium; Oligonucleotide

Indexed keywords

BETA GALACTOSIDASE; OLIGONUCLEOTIDE; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CYTOSOL; ENDOCARDIUM; ENDOTHELIUM CELL; EPICARDIUM; GENE TRANSFER; GENETIC TRANSFECTION; HEART DISEASE; HEART MUSCLE; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS ENVELOPE;

ANIMALIA;

EID: 0031795117     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300750     Document Type: Article

References (28)

1. Leinwand LA, Leiden JM. Gene transfer into cardiac myocytes in vivo. Trends Cardiovasc Med 1991; 1: 271-276.
2. Nabel EG, Pompili VJ, Plautz GE, Nabel GJ. Gene transfer and vascular disease. Cardiavasc Res 1994; 28: 445-455.
3. Lin H et al. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 1990; 82: 2217-2221.
4. Kists R et al. Hormonal modulation of a gene injected into rat heart in vivo. Proc Natl Acad Sci USA 1991; 88: 4138-4142.
5. Eisler AK et al. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and 271 vivo. Proc Natl Acad Sci USA 1993; 90: 11498-11502.
6. Barr E et al. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Therapy 1994; 1: 51-58.
7. Rosenberg SA, Aebersold P, Cornetta K. Gene transfer into humans: immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. New Engl J Med 1990; 323: 570-578.
8. Simons M et al. Antisense c-myb oligonucleotide inhibit intimal arterial smooth muscle cells accumulation in vivo. Nature (Lond) 1992; 359: 67-70.
9. Morishita R et al. Intima hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest 1994; 93: 1458-1464.
10. Kaneda Y, Iwai K, Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 1989; 243: 375-378.
11. Kato K et al. Expression of hepatitis B virus surface antigen in adult rat liver. J Biol Chem 1991; 266: 3361-3364.
12. Tomita N et al. Hypertensive rats produced by in vivo introduction of the human renin gene. Circ Res 1993; 73: 898-905.
13. Morishita R et al. Novel in vivo gene transfer method for study of local modulators in vascular smooth muscle cells. Hypertension 1993; 21: 894-899.
14. Morishita R et al. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotide results in chronic inhibition of neointimal hyperpiasia. Proc Natl Acad Sci USA 1993; 90: 8474-8478.
15. Zhu N, Liggitt D, Liu Y, Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993; 261: 209-211.
16. Ohno T et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994; 265: 781-784.
17. Champman GD et al. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter. Circ Res 1992; 71: 27-33.
18. Ardehali A et al. Direct gene transfer into donor hearts at the time of harvest. J Thorac Cardiovssc Surg 1995; 109: 716-720.
19. Quin L et al. Gene transfer for transplantation. Prolongation of allograft survival with transforming growth factor-β1. Ann Surg 1994; 220: 508-519.
20. Prince GA et al. Pathogenesis of adenovirus type 5 pneumonia in cotton rat (Sigmodon hispidus). J Virol 1993; 67: 101-111.
21. Thompson L. Gene therapy: monkey tests spark safety review. Science 1992; 257: 1854.
22. Hirano T et al. Persistent gene expression in, rat liver in vivo by repetitive transactions using HVJ-Iiposome. Gene Therapy (in press).
23. Yonemitsu Y et al. Characterization of in vivo gene transfer into the arterial wall mediated by the Sendal virus liposomes: an effective tool for the in vivo study of arterial disease. Lab Invest 1996; 75: 313-323.
24. Onishi S. Fusion of viral envelopes with cellular membranes. Curr Top Memb Trans 1988; 32: 257-296.
25. Dzau VJ, Mann MJ, Morishita R, Kaneda Y. Fusigenic viral liposome for gene therapy in cardiovascular disease. Proc Natl Acad Sci USA 1996; 93: 11421-11425.
26. Takahashi H, Fujimoto J, Hanada S, Isselbacher KJ. Acute hepatitis in rats expressing human hepatitis B virus transgenes. Proc Natl Acad Sci USA 1995; 92: 1470-1474.
27. Ono K, Lindsey E. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225-229.
28. Aoki M et al. Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the β-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area. Gene Therapy 1997; 4: 120-127.